Christine Baeder

Christine Baeder, President of Apotex USA, Alfred Engelberg, a retired attorney with a focus on the generic pharmaceutical industry, and Jeremy Greene, a professor at Johns Hopkins, dive into the rising costs of life-saving medications. They discuss the emotional toll on patients facing exorbitant prices and the struggles generics face against patent-holding brand companies. The conversation also covers the implications of recent reforms like the Inflation Reduction Act and the ongoing challenges of ensuring affordable medication access for all.

Christine Baeder, President of Apotex USA, Laura Bray, Founder of Angels for Change, and Craig Burton, Senior VP at the Association for Accessible Medicines, delve into the complexities of America's generic drug market. They discuss the hidden costs of low-priced drugs, including quality issues and shortages. A poignant story about the Bray family's struggle with the life-saving drug Vincristine highlights systemic failures and the emotional toll on patients. The conversation stresses the urgent need for reform to ensure drug availability while balancing affordability and quality.